Objective—α7 nicotinic acetylcholine receptor (α7nAChR) is a subtype of nAChR and has
been reported to be involved in hypertension end-organ damage. In this study, we tested the …

e60 Arterioscler Thromb Vasc Biol June 2017 also one important feature of asthma. A recent
study reported an association between active asthma and AAA in humans. 15 This group …

Objective There is no medical treatment proven to limit abdominal aortic aneurysm (AAA)
progression. This systematic review aimed to summarise available trial evidence on the …

Background: Abdominal aortic aneurysm (AAA), a common disease involving the segmental
expansion and rupture of the aorta, has a high mortality rate. Therapeutic options for AAA …

Abdominal aortic aneurysm (AAA) is a vascular pathology with a high rate of morbidity and
mortality and a prevalence that, in men over 65 years, can reach around 8%. In this disease …

Background Abdominal aortic aneurysms (AAA) rupture can lead to patient death. Surgical
treatment is currently the optimal treatment for AAA with large diameter (≥ 50 mm). For AAA …

The aorta is the largest artery and can be divided into several segments (Fig 1). The
diaphragm divides the aorta into the thoracic and abdominal aorta. The thoracic aorta …

Background Angiotensin II type 1 receptor blockers (ARBs) have been shown to limit the
growth of abdominal aortic aneurysm (AAA), but their efficacy is controversial. This study …

Abdominal aortic aneurysm (AAA) is a potential lethal disease that is defined by an
irreversible dilatation (> 50%) of the aorta. During AAA expansion, the aortic wall is often …

Objective Large abdominal aortic aneurysms (AAAs) present a significant mortality risk.
While numerous medical interventions have been proposed, no drugs have convincingly …